MedTrace Logo

Depomedrol for Genicular Nerve Block.

NCT05893771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-11-29

No results posted yet for this study

Summary

This study is designed to test the efficacy of adding Depomedrol a long-acting steroid to bupivacaine for relieving postoperative pain and reducing opioid requirements following total knee replacement surgery. For this purpose, Depomedrol will be added to bupivacaine for ultrasound-guided Genicular nerve block combined with spinal anesthesia.

Conditions

  • Postoperative Pain

Interventions

DRUG

Methylprednisolone Injection

Ultrasound-guided genicular nerve block comparing Methylprednisolone combined with Bupivacaine to bupivacaine alone. All patients will undergo TKA and will receive spinal anesthesia.

DRUG

Bupivacaine Hcl 0.5% Inj_#2

Ultasound- guided genicular nerve block using 5 ml bupivacaine 0.5% in 15 ml saline

DRUG

normal saline

Ultrasound guided genicular nerve infiltration with 20 ml normal saline as a placebo control.

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-07
Primary Completion
2023-11-27
Completion
2023-11-27

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05893771 on ClinicalTrials.gov